Pharmacogenomics of tamoxifen and aromat
β
James N. Ingle
π
Article
π
2008
π
John Wiley and Sons
π
English
β 83 KB
In selection of therapy for women with breast cancer, the focus has been almost exclusively on the characteristics of the tumor, eg, estrogen receptor (ER) and HER-2. Until recently, essentially no attention has been paid to the host and her genetic makeup as it relates to the metabolism of differen